Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.71 USD | -4.24% | -4.58% | -53.68% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 117 | 58.39 | 284 | 132.1 | - | - |
Enterprise Value (EV) 1 | 90.3 | 58.39 | 284 | 115.2 | 132.1 | 132.1 |
P/E ratio | -5.08 x | -2.39 x | -13.3 x | -5.21 x | -7.19 x | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 5.28 x | 1.89 x | 6.33 x | 2.16 x | 1.55 x | 1.11 x |
EV / Revenue | 4.07 x | 1.89 x | 6.33 x | 1.89 x | 1.55 x | 1.11 x |
EV / EBITDA | -5.88 x | -3.14 x | -18.7 x | -5.32 x | -10.4 x | 28.7 x |
EV / FCF | -4.7 x | -3.21 x | - | -6.23 x | -13.5 x | 52.8 x |
FCF Yield | -21.3% | -31.1% | - | -16.1% | -7.42% | 1.89% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 37,158 | 37,432 | 48,555 | 48,740 | - | - |
Reference price 2 | 3.150 | 1.560 | 5.850 | 2.710 | 2.710 | 2.710 |
Announcement Date | 3/21/22 | 3/27/23 | 3/18/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | 22.16 | 30.93 | 44.86 | 61.1 | 85.1 | 119.4 |
EBITDA 1 | - | - | -15.35 | -18.59 | -15.21 | -21.66 | -12.73 | 4.6 |
EBIT 1 | - | - | -17.94 | -22.37 | -18.78 | -24.32 | -16.3 | 2 |
Operating Margin | - | - | -80.93% | -72.32% | -41.87% | -39.8% | -19.16% | 1.68% |
Earnings before Tax (EBT) 1 | - | - | -17.85 | -24.45 | -19.03 | -26.59 | -19.63 | - |
Net income 1 | -18.5 | -15.6 | -17.85 | -24.45 | -19.17 | -26.63 | -19.68 | - |
Net margin | - | - | -80.54% | -79.04% | -42.74% | -43.59% | -23.13% | - |
EPS 2 | -9.360 | -2.220 | -0.6200 | -0.6534 | -0.4400 | -0.5200 | -0.3767 | - |
Free Cash Flow 1 | - | - | -19.2 | -18.18 | - | -18.5 | -9.8 | 2.5 |
FCF margin | - | - | -86.64% | -58.78% | - | -30.28% | -11.52% | 2.09% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | 54.35% |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 2/8/21 | 3/31/21 | 3/21/22 | 3/27/23 | 3/18/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 5.625 | 6.577 | 6.985 | 7.333 | 7.864 | 8.751 | 9.628 | 10.78 | 11.77 | 12.68 | 13.37 | 14.59 | 15.88 | 17.26 | 18.52 |
EBITDA 1 | -3.886 | -3.838 | -4.688 | -5.257 | -4.52 | -4.178 | -4.148 | -3.597 | -3.079 | -3.306 | -5.66 | -5.602 | -5.376 | -5.042 | -4.352 |
EBIT 1 | -4.672 | -4.827 | -5.445 | -6.051 | -5.458 | -5.44 | -5.094 | -4.934 | -4.403 | -4.347 | -6.297 | -6.241 | -6.032 | -5.746 | -5.471 |
Operating Margin | -83.06% | -73.39% | -77.95% | -82.52% | -69.4% | -62.16% | -52.91% | -45.77% | -37.42% | -34.28% | -47.09% | -42.79% | -37.99% | -33.29% | -29.55% |
Earnings before Tax (EBT) 1 | -2.859 | -5.451 | -5.936 | -7.447 | -5.49 | -5.599 | -5.239 | -5.033 | -4.407 | -4.515 | -6.895 | -6.822 | -6.645 | -6.2 | -5.942 |
Net income 1 | -2.859 | -5.451 | -5.936 | -7.447 | -5.49 | -5.599 | -5.239 | -5.033 | -4.407 | -4.491 | -6.904 | -6.832 | -6.657 | -6.212 | -5.96 |
Net margin | -50.83% | -82.88% | -84.98% | -101.55% | -69.81% | -63.98% | -54.41% | -46.69% | -37.45% | -35.42% | -51.63% | -46.84% | -41.92% | -35.99% | -32.19% |
EPS 2 | -0.1100 | -0.1600 | -0.1600 | -0.2000 | -0.1500 | -0.1453 | -0.1397 | -0.1200 | -0.1000 | -0.0900 | -0.1350 | -0.1325 | -0.1300 | -0.1200 | -0.1200 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/9/21 | 3/21/22 | 5/9/22 | 8/8/22 | 11/14/22 | 3/27/23 | 5/15/23 | 8/7/23 | 11/6/23 | 3/18/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | - | - | 26.8 | - | - | 16.9 | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -19.2 | -18.2 | - | -18.5 | -9.8 | 2.5 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | 0.61 | 1.41 | - | - | - | - |
Capex / Sales | - | - | 2.76% | 4.55% | - | - | - | - |
Announcement Date | 2/8/21 | 3/31/21 | 3/21/22 | 3/27/23 | 3/18/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.68% | 132M | |
+9.24% | 66.8B | |
+10.58% | 18.03B | |
+7.01% | 13.08B | |
+19.90% | 13.3B | |
+16.20% | 9.98B | |
-35.27% | 5.55B | |
-11.44% | 5.54B | |
-4.27% | 4.9B | |
-6.00% | 4.71B |
- Stock Market
- Equities
- AUGX Stock
- Financials Augmedix, Inc.